Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability

Head and neck squamous cell carcinoma (HNSCC) is a remarkably heterogeneous disease with around 50% mortality, a fact that has prompted researchers to try new approaches to improve patient survival. Hemoxygenase-1 (HO-1) is the rate-limiting step for heme degradation into carbon monoxide, free iron...

Descripción completa

Detalles Bibliográficos
Autores principales: Mascaró, Marilina, Alonso, Exequiel G., Schweitzer, Karen, Rabassa, Martín E., Carballido, Jessica A., Ibarra, Agustina, Alonso, Eliana N., Bermúdez, Vicente, Fernández Chavez, Lucía, Coló, Georgina P., Ferronato, María Julia, Pichel, Pamela, Recio, Sergio, Clemente, Valentina, Fermento, Maria Eugenia, Facchinetti, María Marta, Curino, Alejandro C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598840/
https://www.ncbi.nlm.nih.gov/pubmed/36290800
http://dx.doi.org/10.3390/antiox11102077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598840/
https://www.ncbi.nlm.nih.gov/pubmed/36290800
http://dx.doi.org/10.3390/antiox11102077

Ejemplares similares